TimesSquare Capital Management LLC Boosts Holdings in Cellebrite DI Ltd. $CLBT

TimesSquare Capital Management LLC grew its holdings in shares of Cellebrite DI Ltd. (NASDAQ:CLBT) by 18.3% during the 4th quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 715,992 shares of the company’s stock after acquiring an additional 110,630 shares during the quarter. TimesSquare Capital Management LLC owned 0.30% of Cellebrite DI worth $12,909,000 at the end of the most recent quarter.

Several other large investors have also recently made changes to their positions in CLBT. CWM LLC grew its holdings in shares of Cellebrite DI by 85.7% in the third quarter. CWM LLC now owns 1,560 shares of the company’s stock worth $29,000 after purchasing an additional 720 shares during the last quarter. Advisory Services Network LLC bought a new position in shares of Cellebrite DI in the third quarter worth approximately $40,000. First Horizon Corp grew its holdings in shares of Cellebrite DI by 421.8% in the fourth quarter. First Horizon Corp now owns 2,891 shares of the company’s stock worth $52,000 after purchasing an additional 2,337 shares during the last quarter. Vestcor Inc bought a new position in shares of Cellebrite DI in the third quarter worth approximately $70,000. Finally, PNC Financial Services Group Inc. grew its holdings in shares of Cellebrite DI by 114.5% in the third quarter. PNC Financial Services Group Inc. now owns 4,501 shares of the company’s stock worth $83,000 after purchasing an additional 2,403 shares during the last quarter. 45.88% of the stock is owned by hedge funds and other institutional investors.

Analyst Upgrades and Downgrades

CLBT has been the topic of several recent analyst reports. Weiss Ratings upgraded shares of Cellebrite DI from a “sell (d+)” rating to a “hold (c-)” rating in a report on Monday. Wall Street Zen upgraded shares of Cellebrite DI from a “sell” rating to a “hold” rating in a report on Sunday, March 15th. Finally, Needham & Company LLC cut their target price on shares of Cellebrite DI from $18.00 to $15.00 and set a “buy” rating on the stock in a report on Friday, May 15th. Four analysts have rated the stock with a Buy rating and one has assigned a Hold rating to the company’s stock. According to MarketBeat, Cellebrite DI has an average rating of “Moderate Buy” and an average price target of $21.75.

Insiders Place Their Bets

In related news, CRO Marcus Jewell sold 12,658 shares of Cellebrite DI stock in a transaction on Monday, May 18th. The shares were sold at an average price of $12.77, for a total value of $161,642.66. Following the sale, the executive owned 440,101 shares in the company, valued at $5,620,089.77. The trade was a 2.80% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is available at this link. Insiders have sold a total of 13,269 shares of company stock valued at $169,592 in the last quarter. Insiders own 5.70% of the company’s stock.

Cellebrite DI Stock Down 1.2%

NASDAQ:CLBT opened at $13.46 on Wednesday. The stock has a market cap of $3.36 billion, a P/E ratio of 48.07, a price-to-earnings-growth ratio of 1.63 and a beta of 1.15. The firm’s fifty day simple moving average is $13.47 and its 200 day simple moving average is $15.45. Cellebrite DI Ltd. has a twelve month low of $11.02 and a twelve month high of $19.98.

Cellebrite DI Profile

Cellebrite DI is a global provider of digital intelligence and forensics solutions that enable law enforcement agencies, government bodies and enterprises to extract, analyze and act on data from mobile devices, cloud services and digital sources. The company’s technology is designed to accelerate investigations, support evidence-based decision-making and enhance security operations by delivering actionable intelligence in a secure, scalable platform.

The company’s flagship offerings include the Universal Forensic Extraction Device (UFED) series for data acquisition and decoding, Physical Analyzer for advanced data parsing and visualization, and Pathfinder for case-driven investigation workflows.